JP2013528289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013528289A5 JP2013528289A5 JP2013514206A JP2013514206A JP2013528289A5 JP 2013528289 A5 JP2013528289 A5 JP 2013528289A5 JP 2013514206 A JP2013514206 A JP 2013514206A JP 2013514206 A JP2013514206 A JP 2013514206A JP 2013528289 A5 JP2013528289 A5 JP 2013528289A5
- Authority
- JP
- Japan
- Prior art keywords
- output signal
- analyte concentration
- sample
- index function
- bias
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 claims description 135
- 239000012491 analyte Substances 0.000 claims description 115
- 238000012937 correction Methods 0.000 claims description 63
- 239000002131 composite material Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 39
- 238000005259 measurement Methods 0.000 claims description 33
- 238000012360 testing method Methods 0.000 claims description 28
- 239000012472 biological sample Substances 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 18
- 230000004044 response Effects 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 9
- 230000007717 exclusion Effects 0.000 claims description 8
- 230000001419 dependent effect Effects 0.000 claims 2
- 238000004458 analytical method Methods 0.000 description 58
- 238000005534 hematocrit Methods 0.000 description 53
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 33
- 239000008103 glucose Substances 0.000 description 33
- 210000004369 blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 230000003287 optical effect Effects 0.000 description 21
- 239000013060 biological fluid Substances 0.000 description 17
- 230000009467 reduction Effects 0.000 description 15
- 238000006722 reduction reaction Methods 0.000 description 15
- 239000004020 conductor Substances 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000001514 detection method Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000004082 amperometric method Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 5
- 238000006479 redox reaction Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 238000004832 voltammetry Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000004313 potentiometry Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35198810P | 2010-06-07 | 2010-06-07 | |
| US61/351,988 | 2010-06-07 | ||
| PCT/US2011/038329 WO2011156152A1 (en) | 2010-06-07 | 2011-05-27 | Slope-based compensation including secondary output signals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013528289A JP2013528289A (ja) | 2013-07-08 |
| JP2013528289A5 true JP2013528289A5 (cg-RX-API-DMAC7.html) | 2015-03-12 |
| JP5856154B2 JP5856154B2 (ja) | 2016-02-09 |
Family
ID=44501672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013514206A Active JP5856154B2 (ja) | 2010-06-07 | 2011-05-27 | 二次出力シグナルを含む勾配に基づく補正 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9164076B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP3104176B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5856154B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102068949B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103210310B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012031166A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2798938C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2700100T3 (cg-RX-API-DMAC7.html) |
| MX (2) | MX340921B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2577711C2 (cg-RX-API-DMAC7.html) |
| SG (2) | SG186179A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011156152A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8529751B2 (en) * | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
| US8778168B2 (en) | 2007-09-28 | 2014-07-15 | Lifescan, Inc. | Systems and methods of discriminating control solution from a physiological sample |
| US8603768B2 (en) | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| US8551320B2 (en) | 2008-06-09 | 2013-10-08 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
| RU2568884C2 (ru) | 2010-03-22 | 2015-11-20 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Компенсация невязки для биодатчика |
| WO2011156152A1 (en) * | 2010-06-07 | 2011-12-15 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
| JP6082396B2 (ja) | 2011-09-21 | 2017-02-15 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ | 誤差補償を伴うバイオセンサ |
| US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
| US8709232B2 (en) * | 2012-04-30 | 2014-04-29 | Cilag Gmbh International | Analyte measurement technique and system |
| JP6140284B2 (ja) | 2012-07-27 | 2017-05-31 | アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ | 既使用で乾燥したセンサを検出するシステム及び方法 |
| CN110426436B (zh) * | 2013-03-14 | 2022-08-19 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
| EP2972396A1 (en) * | 2013-03-14 | 2016-01-20 | Bayer HealthCare LLC | Normalized calibration of analyte concentration determinations |
| US9459231B2 (en) | 2013-08-29 | 2016-10-04 | Lifescan Scotland Limited | Method and system to determine erroneous measurement signals during a test measurement sequence |
| US9243276B2 (en) | 2013-08-29 | 2016-01-26 | Lifescan Scotland Limited | Method and system to determine hematocrit-insensitive glucose values in a fluid sample |
| CN107636452B (zh) * | 2015-05-15 | 2021-06-08 | 安晟信医疗科技控股公司 | 改进的生物传感器系统分析物测量 |
| CN105021805B (zh) * | 2015-08-21 | 2018-03-06 | 三诺生物传感股份有限公司 | 一种人体生理参数检测结果的校正方法 |
| CA3028348A1 (en) | 2016-07-12 | 2018-01-18 | Ascensia Diabetes Care Holdings Ag | Method for electrochemical analysis by use of alternating output signals from two electrodes |
| EP3548881A1 (en) | 2016-12-05 | 2019-10-09 | Ascensia Diabetes Care Holdings AG | Risk factor monitoring |
| CN113490454A (zh) | 2019-02-05 | 2021-10-08 | 安晟信医疗科技控股公司 | 用于探测连续分析物感测及自动更正的传感器操作的设备及方法 |
| US11445944B2 (en) | 2019-02-22 | 2022-09-20 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for analyte concentration monitoring using harmonic relationships |
| US11678820B2 (en) | 2019-09-10 | 2023-06-20 | Ascensia Diabetes Care Holdings Ag | Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| US5723284A (en) | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| DE69809391T2 (de) | 1997-02-06 | 2003-07-10 | Therasense, Inc. | Kleinvolumiger sensor zur in-vitro bestimmung |
| US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| EP0990151A2 (en) | 1997-06-16 | 2000-04-05 | ELAN CORPORATION, Plc | Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods |
| US7494816B2 (en) * | 1997-12-22 | 2009-02-24 | Roche Diagnostic Operations, Inc. | System and method for determining a temperature during analyte measurement |
| CN1598564B (zh) | 1997-12-22 | 2010-04-21 | 罗赫诊断手术公司 | 测量仪 |
| DE69914319T2 (de) | 1998-05-13 | 2004-11-18 | Cygnus, Inc., Redwood City | Signalverarbeitung zur messung von physiologischen analyten |
| AU3849799A (en) | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| DE60037592T2 (de) | 1999-09-20 | 2009-01-22 | Roche Diagnostics Gmbh | Methode zur Messung eines Analyten mit Hilfe eines elektrochemischen Biosensors, der durch Anlegen eines Potentials abgeschaltet werden kann |
| JP4050434B2 (ja) | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| EP2202511A3 (en) | 2001-01-17 | 2010-09-29 | ARKRAY, Inc. | Quantitative analyzing method and quantitative analyzer using sensor |
| EP1443322B1 (en) | 2001-10-12 | 2013-07-17 | ARKRAY, Inc. | Concentration measuring method and concentration measuring device |
| AU2003234944A1 (en) | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| US7132041B2 (en) | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| KR101114020B1 (ko) | 2003-08-21 | 2012-04-04 | 아가매트릭스, 인코포레이티드 | 전기화학적 성질 분석 방법 및 분석 장치 |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| JP2005156316A (ja) * | 2003-11-25 | 2005-06-16 | Toshiba Corp | マイクロ波式濃度計 |
| WO2005078437A1 (en) * | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Electrochemical biosensor |
| CN1938590B (zh) | 2004-04-19 | 2010-05-05 | 松下电器产业株式会社 | 血液成分的测定方法、该方法中使用的生物传感器和测定装置 |
| US20080304068A1 (en) | 2004-04-28 | 2008-12-11 | Tsuneo Urisu | Biochip Production Method, Biochip, Biochip Analysis Apparatus, and Biochip Analysis Method |
| US7972861B2 (en) | 2004-05-14 | 2011-07-05 | Bayer Healthcare Llc | Methods for performing hematocrit adjustment in glucose assays and devices for same |
| TWI385379B (zh) | 2004-10-12 | 2013-02-11 | Bayer Healthcare Llc | 在擴散障壁層中濃度的測定 |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| CN101179961A (zh) | 2005-03-22 | 2008-05-14 | 伊藤智章 | 信息泄漏防护膜、携带用小物品收容具、卡片盒以及信息泄漏防止板 |
| US7517439B2 (en) | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| CA2890945C (en) | 2005-07-20 | 2016-11-29 | Bayer Healthcare Llc | Gated amperometry |
| EP1910823B1 (en) | 2005-07-26 | 2015-10-21 | Bayer HealthCare LLC | Method and system for checking an electromechanical biosensor |
| KR101477948B1 (ko) | 2005-09-30 | 2014-12-30 | 바이엘 헬스케어 엘엘씨 | 게이트형 전압 전류 측정 분석 구간 결정 방법 |
| CA3044828A1 (en) | 2006-02-27 | 2007-09-07 | Ascensia Diabetes Care Holdings Ag | Temperature adjusted analyte determination for biosensor systems |
| CA2650880C (en) * | 2006-05-08 | 2015-11-24 | Bayer Healthcare Llc | Abnormal output detection system for a biosensor |
| JP5018777B2 (ja) * | 2006-07-05 | 2012-09-05 | パナソニック株式会社 | 液体試料測定方法および装置 |
| CN101517093B (zh) * | 2006-09-22 | 2016-01-06 | 拜尔健康护理有限责任公司 | 具有增强的稳定性和血细胞比容性能的生物传感器系统 |
| US20080248581A1 (en) | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| MX2010006392A (es) * | 2007-12-10 | 2010-07-02 | Bayer Healthcare Llc | Compensacion basada en la pendiente. |
| CN101214152A (zh) * | 2008-01-22 | 2008-07-09 | 天津市先石光学技术有限公司 | 人体血糖浓度的微创、动态、连续检测方法 |
| RU2509304C2 (ru) * | 2008-12-08 | 2014-03-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Биосенсорная система с корректировкой сигнала |
| WO2011156152A1 (en) * | 2010-06-07 | 2011-12-15 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
-
2011
- 2011-05-27 WO PCT/US2011/038329 patent/WO2011156152A1/en not_active Ceased
- 2011-05-27 US US13/117,872 patent/US9164076B2/en active Active
- 2011-05-27 MX MX2012014282A patent/MX340921B/es active IP Right Grant
- 2011-05-27 EP EP16180262.4A patent/EP3104176B1/en active Active
- 2011-05-27 MX MX2016005536A patent/MX369764B/es unknown
- 2011-05-27 KR KR1020197010911A patent/KR102068949B1/ko active Active
- 2011-05-27 SG SG2012089371A patent/SG186179A1/en unknown
- 2011-05-27 SG SG10201507109TA patent/SG10201507109TA/en unknown
- 2011-05-27 EP EP11730482.4A patent/EP2577302B8/en active Active
- 2011-05-27 JP JP2013514206A patent/JP5856154B2/ja active Active
- 2011-05-27 CA CA2798938A patent/CA2798938C/en not_active Expired - Fee Related
- 2011-05-27 RU RU2012157320/15A patent/RU2577711C2/ru active
- 2011-05-27 EP EP18190634.8A patent/EP3431986A1/en not_active Withdrawn
- 2011-05-27 KR KR1020137000447A patent/KR101971233B1/ko active Active
- 2011-05-27 BR BR112012031166A patent/BR112012031166A2/pt not_active IP Right Cessation
- 2011-05-27 ES ES16180262T patent/ES2700100T3/es active Active
- 2011-05-27 CN CN201180039221.4A patent/CN103210310B/zh active Active
-
2015
- 2015-09-04 US US14/846,174 patent/US9995702B2/en active Active
-
2018
- 2018-05-22 US US15/986,539 patent/US10921278B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5856154B2 (ja) | 二次出力シグナルを含む勾配に基づく補正 | |
| JP2013528289A5 (cg-RX-API-DMAC7.html) | ||
| JP5738770B2 (ja) | 信号調整を持つバイオセンサシステム | |
| JP6448504B2 (ja) | 勾配ベース補正 | |
| US11988626B2 (en) | Residual compensation including underfill error | |
| JP2012511160A5 (cg-RX-API-DMAC7.html) | ||
| JP2011506966A5 (cg-RX-API-DMAC7.html) | ||
| HK1181850B (en) | Slope-based compensation including secondary output signals | |
| HK1177260B (en) | Residual compensation for a biosensor | |
| HK1179346B (en) | Biosensor system with signal adjustment |